← Back to Search

Vibrating Wand + Lidocaine for Spasmodic Dysphonia

N/A
Recruiting
Led By William Karle, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 months, 6 months
Awards & highlights

Study Summary

This trial is testing different ways to make patients more comfortable during in-office laryngology procedures.

Eligible Conditions
  • Spasmodic Dysphonia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 months, 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 months, 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in pain experienced

Trial Design

3Treatment groups
Experimental Treatment
Group I: Vibrating WandExperimental Treatment1 Intervention
Patients will receive laryngeal injection of Botox via a transcricothyroid approach while a vibrating instrument is held adjacent to cricothyroid space
Group II: LidocaineExperimental Treatment1 Intervention
Patients will receive laryngeal injection of Botox via a transcricothyroid approach following subcutaneous injection of 0.5cc 2% lidocaine in 1:100,000 epinephrine (done approximately 2 minutes before Botox injection)
Group III: ControlExperimental Treatment1 Intervention
Patients will receive laryngeal injection of Botox via a transcricothyroid approach without additional anesthesia
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Lidocaine
FDA approved

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,207 Previous Clinical Trials
3,767,090 Total Patients Enrolled
William Karle, MDPrincipal InvestigatorMayo Clinic
David Lott, MDPrincipal InvestigatorMayo Clinic
1 Previous Clinical Trials
10 Total Patients Enrolled

Media Library

Vibrating wand Clinical Trial Eligibility Overview. Trial Name: NCT04648891 — N/A
Spasmodic Dysphonia Research Study Groups: Control, Vibrating Wand, Lidocaine
Spasmodic Dysphonia Clinical Trial 2023: Vibrating wand Highlights & Side Effects. Trial Name: NCT04648891 — N/A
Vibrating wand 2023 Treatment Timeline for Medical Study. Trial Name: NCT04648891 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Spasmodic Dysphonia Pain
David G. Lott, M.D. 2021. "Spasmodic Dysphonia Pain". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04648891.
~14 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top